Psychosis
Self-medication may explain the link between psychosis and cannabis use in adolescents
Young adolescents who used cannabis more frequently reportedpsychosis spectrum symptoms and greater distress from such symptoms, according to results of a cohort study published in JAMA Psychiatry.
High-dose amphetamine increases odds of psychosis, mania by fivefold
Patients with past-month exposure to prescription amphetamines used to treat ADHD had higher odds of developing psychosis or mania compared with those without past-month exposure, according to a recent study.
VIDEO: Case-based collaborative learning useful in psychoeducation
NEW YORK — In this Healio Video Perspective, Hyun Jung Kim, MD, discusses the format of her presentation on the relationship between cannabis use and risk for psychosis at the American Psychiatric Association Annual Meeting.
VIDEO: Co-occurring schizophrenia, stimulant use disorder ‘challenging’ to treat
NEW YORK — The prevalence of substance use disorders is high among patients with schizophrenia, Randall F. White, MD, said in this Healio Video Perspective from the American Psychiatric Association Annual Meeting.
Psychosis may be linked to ovarian dysfunction conditions in adolescent females
NEW YORK — Gynecological conditions with hormonal derangements may contribute to secondary psychosis among adolescent females, according to results of a literature review presented at the American Psychiatric Association Annual Meeting.
Impact of interpreter use on psychiatric treatment, care access requires further study
NEW YORK — Additional research concerning the impact of using interpreters for psychiatric care for patients with limited English proficiency is needed, according to a poster presented at the American Psychiatric Association Annual Meeting.
Lack of sleep in childhood increases risk of psychosis in early adulthood
Persistent shorter sleep durations during childhood were associated with a greater risk of psychosis disorder and psychotic episodes during early adulthood, a study in JAMA Psychiatry showed.
Antipsychotics may prevent relapse in first-episode psychosis with cannabis use disorder
Some antipsychotics other than olanzapine lowered the risk for hospitalization due to psychotic relapse among individuals with first-episode psychosis and co-occurring cannabis use disorder, according to a study in Schizophrenia Bulletin.
Repetitive transcranial magnetic stimulation alleviates psychomotor slowing from psychosis
Three weeks of 1-Hz repetitive transcranial magnetic stimulation effectively alleviated psychomotor slowing among people with schizophrenia spectrum disorder, according to a study published in JAMA Psychiatry.
Bristol Myers Squibb announces merger with Karuna Therapeutics
Bristol Myers Squibb and Karuna Therapeutics Inc. announced a definitive merger agreement that includes Karuna’s lead asset, a muscarinic receptor agonist to treat schizophrenia and Alzheimer’s disease psychosis.